ArticleCureus2026
Utility of Pelvic Magnetic Resonance Imaging in a Younger Population.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePelvic examinations and transvaginal ultrasonography are generally deferred in patients without sexual experience due to potential distress. Transabdominal ultrasonography is widely used but may have variable image quality. Pelvic magnetic resonance imaging (MRI) serves as an alternative to evaluate underlying pathologies. This study investigated the clinical utility of pelvic MRI by comparing clinical presentations and management between adolescents and adults.
methodsIn this single-center, retrospective cohort study, we analyzed 262 female patients without sexual experience (63 adolescents, 10-19 years; 199 adults, ≥20 years) who underwent pelvic MRI between 2024 and 2025. MRI was performed to rule out organic disease. Findings were categorized into organic or functional diseases. Post-imaging therapeutic interventions (hormonal therapy, surgery, symptomatic treatment, and referral) were compared between groups.
resultsAbnormal MRI findings were observed in 87.4% of the cohort. Functional diseases predominated in adolescents (49.2% vs. 34.7%, p<0.001), whereas organic diseases were more prevalent in adults (76.4% vs. 33.3%, p<0.001). The therapeutic intervention rate was significantly higher in adolescents (74.6% vs. 49.2%, p<0.001). Hormonal therapy was the primary treatment in both groups, exceeding 60% in each. However, symptomatic treatment was more frequent in adolescents, whereas surgery was more common in adults (both p<0.05).
conclusionsGynecological care for this population must address distinct age-specific clinical profiles. Adolescent organic disease prevalence is higher than expected, with hormonal intervention rates equivalent to adults. In community practice, pelvic MRI effectively guides management to optimize comprehensive women's health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.